Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids.
HumanStem cell reports · 2025
Researchers studied brain organoids to understand Alzheimer’s disease and found that a protein called thymosin beta 4 (Tβ4) is significantly reduced in neurons affected by the disease. They observed that treatment with Tβ4 improved neuron development and reduced harmful protein buildup in both brain organoids and mouse models. This suggests Tβ4 could be a promising target for future Alzheimer’s interventions.
- Researchers found that neurons in Alzheimer’s disease organoids had fewer mature cells and increased harmful protein production compared to healthy controls.
- The gene TMSB4X, which produces thymosin beta 4, was significantly lower in Alzheimer’s affected neurons.
- Treatment with Tβ4 improved neuron development and reduced harmful protein levels in both brain organoids and mouse models of Alzheimer’s disease.